Comparison of Sebia Capillarys 3-OCTA with the Tosoh Bioscience HLC^®-723G8 method for A1C testing with focus on analytical interferences and variant detection

Articles in the same Issue

1. Frontmatter
2. Editorials
3. Clinical Chemistry and Laboratory Medicine: enjoying the present and assessing the future
4. Rethinking internal quality control: the time is now
5. Review
6. Multi-omics analysis from archival neonatal dried blood spots: limitations and opportunities
7. Opinion Papers
8. ‘Penelope test’: a practical instrument for checking appropriateness of laboratory tests
9. Interference by macroprolactin in assays for prolactin: will the In Vitro Diagnostics Regulation lead to a solution at last?
10. EFLM Paper
11. Efficiency, efficacy and subjective user satisfaction of alternative laboratory report formats. An investigation on behalf of the Working Group for Postanalytical Phase (WG-POST), of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)
12. General Clinical Chemistry and Laboratory Medicine
13. Cross-reactivity in assays for prolactin and optimum screening policy for macroprolactinaemia
14. Repository of intra- and inter-run variations of quantitative autoantibody assays: a European multicenter study
15. Stability of direct renin concentration and plasma renin activity in EDTA whole blood and plasma at ambient and refrigerated temperatures from 0 to 72 hours
16. Comparison of four different immunoassays and a rapid isotope-dilution liquid chromatography-tandem mass spectrometry assay for serum folate
17. Analytical quality specifications in semen analysis according to the state of the current methodologies
18. Reference Values and Biological Variations
19. Short-term biological variation study of plasma hemophilia and thrombophilia parameters in a population of apparently healthy Caucasian adults
20. First morning voided urinary gonadotropins in children: verification of method performance and establishment of reference intervals
21. Derivation of sex and age-specific reference intervals for clinical chemistry analytes in healthy Ghanaian adults
22. Cancer Diagnostics
23. Serum free light chain analysis: persisting limitations with new kids on the block
24. Cardiovascular Diseases
25. Age partitioned and continuous upper reference limits for Ortho VITROS High Sensitivity Troponin I in a healthy paediatric cohort
26. The predictive value of hemoglobin to creatinine ratio for contrast-induced nephropathy in percutaneous coronary interventions
27. Infectious Diseases
28. Health technology assessment to employ COVID-19 serological tests as companion diagnostics in the vaccination campaign against SARS-CoV-2
29. Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay
30. Presepsin levels in neonatal cord blood are not influenced by maternal SARS-CoV-2 infection
31. Letters to the Editors
32. How to evaluate fixed clinical QC limits vs. risk-based SQC strategies
33. Reply to Westgard et al.: ‘Keep your eyes wide … as the present now will later be past’*
34. Platelet phagocytosis by monocytes
35. Early detection of Candida parapsilosis in peripheral blood as a result of a peripheral blood smear performed after cytographic changes on the Beckman Coulter UniCel DxH 800 hematology
36. Pseudo-erythroblastosis on Sysmex XN hematology analyzers: a clue to Candida sepsis. Case report and literature review
37. Covert poisoning with difenacoum: diagnosis and follow-up difficulties
38. Comparison of Sebia Capillarys 3-OCTA with the Tosoh Bioscience HLC^®-723G8 method for A1C testing with focus on analytical interferences and variant detection